After 16 years growing a biotech drug testing startup into a $35 million corporate buyout, Paul Silber is ready to change gears.

Recently named the new chair of the Greater Baltimore Technology Council?s Biotech Roundtable, Silber can?t go from “100 miles an hour” running his own company and managing the transition to full-time hobby gardener.

Recommended Stories

Appeals court rejects DOJ effort to set aside 20,000 mail-in ballots, teeing up Supreme Court gambit

Illegal immigrant charged with impersonating CIA official using scam agency

Russia shuts down last independent newspaper